Targeted therapy for hepatocellular carcinoma: Challenges and opportunities.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer letters"
DOI: 10.1016/j.canlet.2019.114428
Abstract: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, which ranks as the sixth of cancer-related death. Despite the emergence of targeted therapy, advanced-stage HCC remains largely incurable due to low response rate… read more here.
Keywords: hepatocellular carcinoma; therapy hepatocellular; hcc; targeted therapy ... See more keywords
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
Sign Up to like & getrecommendations! Published in 2021 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100129
Abstract: With increasing therapeutic options available for advanced hepatocellular carcinoma (HCC), the timing and sequencing of locoregional and systemic therapy need to be re-examined. This is especially so for patients with intermediate HCC, so as to… read more here.
Keywords: hepatocellular carcinoma; therapy hepatocellular; carcinoma start; locoregional therapy ... See more keywords
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials
Sign Up to like & getrecommendations! Published in 2019 at "Liver Cancer"
DOI: 10.1159/000501501
Abstract: The major histocompatibility complex on antigen-presenting cells recognizes tumorassociated antigens on the surface of cancer cells and presents the antigen to T-cell receptors on immature T cells upon migration of antigen-presenting cells to the lymph… read more here.
Keywords: hepatocellular carcinoma; oncology therapy; therapy hepatocellular; immuno oncology ... See more keywords
Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update
Sign Up to like & getrecommendations! Published in 2020 at "Liver Cancer"
DOI: 10.1159/000511001
Abstract: Systemic therapy for hepatocellular carcinoma (HCC) has changed markedly since the introduction of the molecular targeted agent sorafenib in 2007. Sorafenib increased the available treatment options for patients with extrahepatic spread and vascular invasion and… read more here.
Keywords: hepatocellular carcinoma; therapy hepatocellular; line; systemic therapy ... See more keywords